Clovis Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
January 2, 2019
BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its Chief
Executive Officer and President, Patrick J. Mahaffy, will present at the
37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8,
2019 at 4:30 p.m. Pacific time. The conference will be held at the
Westin St. Francis Hotel in San Francisco.
A live webcast of the presentation and Q&A session can be accessed
through the investor relations section of the Company’s website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be
available on the Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops, with partners, diagnostic
tools intended to direct a compound in development to the population
that is most likely to benefit from its use. Clovis Oncology is
headquartered in Boulder, Colorado, and has additional offices in San
Francisco and Oakland, California and Cambridge, UK. Please visit clovisoncology.com
for more information.
Contacts
Clovis Oncology
Anna Sussman
303.625.5022
asussman@clovisoncology.com
or
Breanna
Burkart
303.625.5023
bburkart@clovisoncology.com